Literature DB >> 31220578

Phenolic cyclobutantetraol esters from Scindapsus officinalis (Roxb.) Schott.

Jinqian Yu1, Xiaowei Sun1, Yan Mu2, Xingang Shi3, Xueyong Wang4, Xiao Wang5.   

Abstract

Five new caffeoyl cyclobutantetraol esters (1-5) and one hydroxycinnamoyl cyclobutantetraol ester (6), were isolated from Scindapsus officinalis (Roxb.) Schott, which were the first reported phenolic metabolites incorporating a cyclobutantetraol in nature. Structures of the isolated compounds, including absolute configurations, were elucidated by spectroscopic analysis, especially 2D NMR techniques and exciton chirality CD (ECCD) method. All isolates were evaluated for cytotoxic activity toward MCF-7 human breast cancer cell, anti-inflammatory activity against nitric oxide (NO) production, and their antioxidative activity in the 1,1-diphenyl-2-picrylhydrazyl assay in vitro. Compound 1 showed strong antioxidative activity with IC50 value of 59.2 μM, and compounds 1-6 exhibited weak inhibitory effects on NO production, while hardly showing any cytotoxic effects against MCF-7 cell.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-inflammatory activity; Antioxidative activity; Caffeoyl cyclobutantetraol ester; Cytotoxic activity; Hydroxycinnamoyl cyclobutantetraol ester; Scindapsus officinalis

Mesh:

Substances:

Year:  2019        PMID: 31220578     DOI: 10.1016/j.fitote.2019.104244

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  1 in total

1.  An efficient method to obtain anti-inflammatory phenolic derivatives from Scindapsus officinalis (Roxb.) Schott. by a high speed counter-current chromatography coupled with a recycling mode.

Authors:  Jinqian Yu; Xiaowei Sun; Lei Zhao; Xueyong Wang; Xiao Wang
Journal:  RSC Adv       Date:  2020-03-17       Impact factor: 3.361

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.